Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,226 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06893913Recruiting
Fasting plus exercise for dry eyes in psoriasis
This study tests whether adding a simple exercise (pyramidal exercise) to intermittent fasting can help reduce dry eyes in people who have psoriasis, prediabetes, and mild obesity. It aims to see if lifestyle changes can improve eye moisture.
Giza, DokkiAges 45–55 - NCT06892964Recruiting
Italian registry and biobank for ML patients
This study creates a national registry and biobank to collect medical information and biological samples from people with any type of ML, helping research into the condition.
RomaAges Up to 100 years - NCT06894576Recruiting
Creating a risk score for blood clot recurrence and bleeding in cancer patients
This study is for people with cancer who have had a serious blood clot. Researchers want to create a risk score that predicts who might have another clot or a bleeding problem from treatment, so they can better tailor care.
Ottawa, OntarioAges 18 years+ - NCT04005638Recruiting
Biobank for people with autoimmune blood cell disorders
This study collects and stores biological samples (a “biobank”) from people with autoimmune cytopenia, so researchers can learn more about the condition. If you qualify, your samples may help future studies and improve care, and it’s based on voluntary consent.
PessacAges 18 years+ - NCT05976815Recruiting
Exercise added to chemotherapy before breast cancer surgery
This study tests whether adding a supervised physical exercise program around the time of “before-surgery” chemotherapy helps people with newly diagnosed breast cancer. You may be assigned to an exercise group or a usual-care group, and the researchers will compare outcomes between them.
Vila Nova de Gaia, Porto DistrictAges 18 years+ - NCT05416164Recruiting
Testes less radiation after a complete response to medicines
This study checks whether some people with breast cancer who have no remaining cancer after medicine (neoadjuvant systemic therapy) can safely receive less radiation. It may help reduce side effects while still keeping cancer controlled.
Amsterdam, North HollandAges 18 years+ - NCT05473156RecruitingPhase 1/Phase 2
Study of AP203 for advanced solid tumors that grew despite treatment
This early-phase study tests AP203 (an investigational treatment) to see if it is safe and to look for signs it can shrink or control certain advanced cancers. The study includes a dose-finding part for many solid tumors, and a second part focused on specific lung and head/neck cancers that previously received PD-1/PD-L1 therapy.
TaipeiAges 18 years+ - NCT06069362Recruiting
Manual Physiotherapy for Neck and Arm Pain
This study tests whether a type of hands-on physical therapy (manual therapy) can help reduce neck and arm pain. It looks at how your body senses touch and pressure to see if that predicts how well you respond.
San Sebastián, GipuzkoaAges 18–80 - NCT05984745RecruitingPhase 2
CoQ10 for fatty liver linked to metabolic issues
This study tests if CoQ10 (a natural supplement) can improve liver health in people with metabolic dysfunction-associated fatty liver disease (MAFLD). It may help if you have a fatty liver and related metabolic issues like high blood pressure or diabetes.
CairoAges 18–80 - NCT06076551Recruiting
Sex differences in small blood vessel problems of the heart
This study looks at how small blood vessels in the heart work differently in men and women who have chest pain but no major blockages in their main heart arteries. The goal is to better understand and treat these smaller vessel issues.
SeoulAges 20–80 - NCT06150365RecruitingEarly Phase 1
Personalized T-cell therapy for advanced solid tumors (KSX01-TCRT)
This study tests a personalized treatment made from your own immune cells (T cells) that are re-engineered to recognize and attack your specific tumor. It is for people with advanced solid tumors that have not responded to other treatments. If you qualify, you will have a blood draw and a tumor sample collected to create your own custom T cell therapy.
BeijingAges 18–70 - NCT06718426Recruiting
Testing Fertitonex for varicocele and infertility
This study tests if a medicine called Fertitonex can improve sperm quality in men who have varicocele (enlarged veins in the scrotum) and are having trouble getting their partner pregnant for the first time.
Shebin El-Kom, MenoufiaAges 18 years+ - NCT06762626Recruiting
Comparing two methods of timing a frozen embryo transfer
This trial compares a new method to time a frozen embryo transfer (using a test called ERA) with the standard method. The goal is to find the best time to transfer a high-quality embryo in women who have had multiple failed IVF attempts (recurrent implantation failure).
Hong KongAges 18–40 - NCT06755034Recruiting
Single implant to hold lower denture on preferred chewing side
This study tests whether a single dental implant placed in the canine area of your preferred chewing side can better stabilize your lower denture. It may be an option if you are at least 60 years old, have full upper and lower dentures that fit well or can be adjusted, and have healthy jawbone in the front area.
Geneva, Canton of GenevaAges 60 years+ - NCT06846086RecruitingPhase 3
Melatonin for heart muscle protection
This trial tests if adding melatonin to standard heart medication helps protect the heart muscle in people with cardiomyopathy. If you are stable on your current heart meds, you may be able to join.
Dakahlia, Egypt, MansouraAges 18 years+ - NCT06887244Recruiting
Nurse phone support before colonoscopy
This trial studies whether a nurse phone call before an elective colonoscopy can improve the procedure experience, reduce anxiety, and lower financial stress.
NaplesAges 18–80 - NCT07267819Recruiting
Xeomin for migraines after a brain injury or health incident
This trial looks at whether Xeomin (a shot that relaxes muscles) helps prevent migraines in people who have had a traumatic brain injury or an unexplained health event, such as a blast or sudden illness. It is for U.S. government employees and their families who have already tried Xeomin at a U.S. military or medical facility.
Bethesda, MarylandAges 18 years+ - NCT07268326Recruiting
Plant-based diet for rheumatoid arthritis
This trial tests whether a plant-based diet can help people with rheumatoid arthritis who have mild disease activity. You must have had RA for at least a year, be on stable medication, and not smoke or take prednisolone.
FrederiksbergAges 18 years+ - NCT07264296Enrolling by invitation
Infection after bone cancer surgery with a big joint implant
This trial studies infections that happen after surgery for bone cancer where a large artificial joint is placed. It aims to understand why some patients get infections, which may lead to better prevention or treatment.
GothenburgAges Any age - NCT07261553Recruiting
Exercises at home for muscle and bone conditions
This study looks at how well people follow a home exercise program for muscle or bone problems. It aims to understand what helps or makes it hard to stick with the exercises.
Konya, KonyaAges 18 years+ - NCT07266116RecruitingPhase 1/Phase 2
TQB2934 injection for light chain amyloidosis
This trial tests a new injectable drug called TQB2934 for people with systemic light chain amyloidosis. It aims to see if the drug is safe and effective for those whose disease has come back or gotten worse after previous treatment.
Beijing, Beijing MunicipalityAges 18–80 - NCT07262333RecruitingPhase 1
Single dose of hydroxynidone for kidney disease patients
This trial tests a single dose of the study drug hydroxynidone in people with different levels of kidney function, including healthy volunteers and those with kidney disease. The goal is to learn how the drug works in the body when kidneys are not working normally.
Hubei, WuhanAges 18–70 - NCT07262567RecruitingPhase 3
New drug vs chemo for KRAS G12D pancreatic cancer
This study tests a new targeted drug, GFH375, against standard chemotherapy for people with advanced pancreatic cancer that has a specific genetic change called KRAS G12D. The goal is to see if the new drug works better and has fewer side effects.
Beijing, Beijing MunicipalityAges 18–80 - NCT07261631RecruitingPhase 1
A study of a new radioactive drug for advanced solid tumors
This trial tests a new radioactive drug called [177Lu]Lu-DFC413 for people with certain advanced solid tumors that have stopped responding to standard treatments. The drug is designed to target cancer cells with a specific marker seen on a special scan.
Princeton, New JerseyAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,226 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.